{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:13:38Z","timestamp":1785388418205,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T00:00:00Z","timestamp":1547769600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Exxon Mobil Foundation","award":["Charitable donation"],"award-info":[{"award-number":["Charitable donation"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12936-019-2645-x","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T14:04:01Z","timestamp":1547820241000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["An online mapping database of molecular markers of drug resistance in Plasmodium falciparum: the ACT Partner Drug Molecular Surveyor"],"prefix":"10.1186","volume":"18","author":[{"given":"Sabina Dahlstr\u00f6m","family":"Otienoburu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Suay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel V.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suttipat","family":"Srisutham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Bj\u00f6rkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina S.","family":"Humphreys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,18]]},"reference":[{"key":"2645_CR1","unstructured":"WHO. World malaria report 2017. Geneva: World Health Organization. \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/259492\/1\/9789241565523-eng.pdf?ua=1\n                    \n                  . Accessed Jan 2018."},{"key":"2645_CR2","doi-asserted-by":"publisher","first-page":"9109","DOI":"10.1073\/pnas.85.23.9109","volume":"85","author":"AF Cowman","year":"1988","unstructured":"Cowman AF, Morry MJ, Biggs BA, Cross GA, Foote SJ. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc Natl Acad Sci USA. 1988;85:9109\u201313.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2645_CR3","doi-asserted-by":"publisher","first-page":"9114","DOI":"10.1073\/pnas.85.23.9114","volume":"85","author":"DS Peterson","year":"1988","unstructured":"Peterson DS, Walliker D, Wellems TE. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Natl Acad Sci USA. 1988;85:9114\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2645_CR4","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1128\/AAC.43.12.2943","volume":"43","author":"RN Price","year":"1999","unstructured":"Price RN, Cassar C, Brockman A, Duraisingh M, van Vugt M, White NJ, et al. The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob Agents Chemother. 1999;43:2943\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"2645_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJM200101253440403","volume":"344","author":"A Djimd\u00e9","year":"2001","unstructured":"Djimd\u00e9 A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourt\u00e9 Y, et al. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med. 2001;344:257\u201363.","journal-title":"N Engl J Med"},{"key":"2645_CR6","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1128\/AAC.00875-06","volume":"51","author":"GS Humphreys","year":"2007","unstructured":"Humphreys GS, Merinopoulos I, Ahmed J, Whitty CJM, Mutabingwa TK, Sutherland CJ, et al. Amodiaquine and artemether\u2013lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. Antimicrob Agents Chemother. 2007;51:991\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"2645_CR7","doi-asserted-by":"publisher","first-page":"833","DOI":"10.4269\/ajtmh.14-0031","volume":"91","author":"M Venkatesan","year":"2014","unstructured":"Venkatesan M, Gadalla NB, Stepniewska K, Dahal P, Nsanzabana C, Moriera C, et al. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P falciparum malaria after artemether\u2013lumefantrine and artesunate\u2013amodiaquine. Am J Trop Med Hyg. 2014;91:833\u201343.","journal-title":"Am J Trop Med Hyg."},{"key":"2645_CR8","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0140-6736(01)06040-8","volume":"358","author":"A Djimd\u00e9","year":"2001","unstructured":"Djimd\u00e9 A, Doumbo OK, Steketee RW, Plowe CV. Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria. Lancet. 2001;358:890\u20131.","journal-title":"Lancet"},{"key":"2645_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.meegid.2005.09.001","volume":"6","author":"G Holmgren","year":"2006","unstructured":"Holmgren G, Gil JP, Ferreira PM, Veiga MI, Obonyo CO, Bj\u00f6rkman A. Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y. Infect Genet Evol. 2006;6:309\u201314.","journal-title":"Infect Genet Evol."},{"key":"2645_CR10","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1086\/596738","volume":"199","author":"C Sisowath","year":"2009","unstructured":"Sisowath C, Petersen I, Veiga MI, M\u00e5rtensson A, Premji Z, Bj\u00f6rkman A, et al. In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether\u2013lumefantrine in Africa. J Infect Dis. 2009;199:750\u20137.","journal-title":"J Infect Dis"},{"key":"2645_CR11","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1128\/AAC.00638-09","volume":"53","author":"L Mwai","year":"2009","unstructured":"Mwai L, Kiara SM, Abdirahman A, Pole L, Rippert A, Diriye A, et al. In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1. Antimicrob Agents Chemother. 2009;53:5069\u201373.","journal-title":"Antimicrob Agents Chemother"},{"key":"2645_CR12","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1128\/AAC.01412-09","volume":"54","author":"SL Nsobya","year":"2010","unstructured":"Nsobya SL, Kiggundu M, Nanyunja S, Joloba M, Greenhouse B, Rosenthal PJ. In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda. Antimicrob Agents Chemother. 2010;54:1200\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"2645_CR13","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","volume":"364","author":"RN Price","year":"2004","unstructured":"Price RN, Uhlemann A-C, Brockman A, McGready R, Ashley E, Phaipun L, et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet. 2004;364:438\u201347.","journal-title":"Lancet"},{"key":"2645_CR14","doi-asserted-by":"publisher","first-page":"e0162718","DOI":"10.1371\/journal.pone.0162718","volume":"11","author":"H Maiga","year":"2016","unstructured":"Maiga H, Lasry E, Diarra M, Sagara I, Bamadio A, Traore A, et al. Seasonal malaria chemoprevention with sulphadoxine\u2013pyrimethamine and amodiaquine selects pfdhfr-dhps quintuple mutant genotype in Mali. PLoS ONE. 2016;11:e0162718.","journal-title":"PLoS ONE"},{"key":"2645_CR15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.pt.2013.07.008","volume":"29","author":"M Venkatesan","year":"2013","unstructured":"Venkatesan M, Alifrangis M, Roper C, Plowe CV. Monitoring antifolate resistance in intermittent preventive therapy for malaria. Trends Parasitol. 2013;29:497\u2013504.","journal-title":"Trends Parasitol."},{"key":"2645_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12936-018-2242-4","volume":"17","author":"RF Grais","year":"2018","unstructured":"Grais RF, Laminou IM, Woi-Messe L, Makarimi R, Bouriema SH, Langendorf C, et al. Molecular markers of resistance to amodiaquine plus sulfadoxine\u2013pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger. Malar J. 2018;17:98.","journal-title":"Malar J."},{"key":"2645_CR17","doi-asserted-by":"publisher","first-page":"979","DOI":"10.4269\/ajtmh.2011.11-0071","volume":"85","author":"TT Thomsen","year":"2011","unstructured":"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, et al. Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy. Am J Trop Med Hyg. 2011;85:979\u201383.","journal-title":"Am J Trop Med Hyg"},{"key":"2645_CR18","doi-asserted-by":"publisher","first-page":"696","DOI":"10.4269\/ajtmh.2004.71.696","volume":"71","author":"K Mugittu","year":"2004","unstructured":"Mugittu K, Ndejembi M, Malisa A, Lemnge M, Premji Z, Mwita A, et al. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance. Am J Trop Med Hyg. 2004;71:696\u2013702.","journal-title":"Am J Trop Med Hyg"},{"key":"2645_CR19","unstructured":"WHO Evidence Review Group. Intermittent preventive treatment of malaria in pregnancy (IPTp) with sulfadoxine\u2013pyrimethamine (SP) Geneva: World Health Organization; 2012. \n                    http:\/\/www.who.int\/malaria\/mpac\/sep2012\/iptp_sp_erg_meeting_report_july2012.pdf\n                    \n                  . Accessed Jan 2018."},{"key":"2645_CR20","unstructured":"WHO. Updated WHO policy recommendation. Geneva: World Health Organization; 2012. \n                    http:\/\/www.who.int\/malaria\/iptp_sp_updated_policy_recommendation_en_102012.pdf\n                    \n                  . Accessed Jan 2018."},{"key":"2645_CR21","unstructured":"The Millennium Development Goals Report 2015. \n                    http:\/\/www.un.org\/millenniumgoals\/2015_MDG_Report\/pdf\/MDG\/2015\/rev(July1).pdf\n                    \n                  . Accessed Jan 2018."},{"key":"2645_CR22","unstructured":"WHO. Malaria Threats Map: tracking biological challenges to malaria control and elimination. Geneva: World Health Organization; 2018. \n                    http:\/\/apps.who.int\/malaria\/maps\/threats\/\n                    \n                  . Accessed Jan 2018."},{"key":"2645_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12936-016-1387-2","volume":"15","author":"RA Kavishe","year":"2016","unstructured":"Kavishe RA, Kaaya RD, Nag S, Krogsgaard C, Notland JG, Kavishe AA, et al. Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine\u2013pyrimethamine in Tanzania. Malar J. 2016;15:335.","journal-title":"Malar J."},{"key":"2645_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2307\/974902","volume":"34","author":"NL Henry","year":"1974","unstructured":"Henry NL. Knowledge management: a new concern for public administration. Public Adm Rev. 1974;34:189.","journal-title":"Public Adm Rev."},{"key":"2645_CR25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1473-3099(16)30415-7","volume":"17","author":"B Witkowski","year":"2017","unstructured":"Witkowski B, Duru V, Khim N, Ross LS, Saintpierre B, Beghain J, et al. A surrogate marker of piperaquine-resistant\u00a0Plasmodium falciparum\u00a0malaria: a phenotype\u2013genotype association study. Lancet Infect Dis. 2017;17:174\u201383.","journal-title":"Lancet Infect Dis."},{"key":"2645_CR26","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S1473-3099(16)30409-1","volume":"17","author":"R Amato","year":"2017","unstructured":"Amato R, Lim P, Miotto O, Amaratunga C, Dek D, Pearson RD, et al. Genetic markers associated with dihydroartemisinin\u2013piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype\u2013phenotype association study. Lancet Infect Dis. 2017;17:164\u201373.","journal-title":"Lancet Infect Dis."},{"key":"2645_CR27","unstructured":"WWARN. ACT Partner Drug Molecular Surveyor 2015. \n                    http:\/\/www.wwarn.org\/tracking-resistance\/act-partner-drug-molecular-surveyor\n                    \n                  . Accessed May 2018."},{"key":"2645_CR28","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1086\/500951","volume":"193","author":"D Francis","year":"2006","unstructured":"Francis D, Nsobya SL, Talisuna A, Yeka A, Kamya MR, Machekano R, et al. Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance. J Infect Dis. 2006;193:978\u201386.","journal-title":"J Infect Dis"},{"key":"2645_CR29","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1128\/AAC.00012-07","volume":"51","author":"SL Nsobya","year":"2007","unstructured":"Nsobya SL, Dokomajilar C, Joloba M, Dorsey G, Rosenthal PJ. Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate\u2013amodiaquine in Uganda. Antimicrob Agents Chemother. 2007;51:3023\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"2645_CR30","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/infdis\/jiu044","volume":"210","author":"S Tukwasibwe","year":"2014","unstructured":"Tukwasibwe S, Mugenyi L, Mbogo GW, Nankoberanyi S, Maiteki-Sebuguzi C, Joloba ML, et al. Differential prevalence of transporter polymorphisms in symptomatic and asymptomatic falciparum malaria infections in Uganda. J Infect Dis. 2014;210:154\u20137.","journal-title":"J Infect Dis"},{"key":"2645_CR31","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/infdis\/jiu141","volume":"210","author":"MD Conrad","year":"2014","unstructured":"Conrad MD, LeClair N, Arinaitwe E, Wanzira H, Kakuru A, Bigira V, et al. Comparative impacts over 5\u00a0years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan children. J Infect Dis. 2014;210:344\u201353.","journal-title":"J Infect Dis"},{"key":"2645_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1475-2875-13-95","volume":"13","author":"S Nankoberanyi","year":"2014","unstructured":"Nankoberanyi S, Mbogo GW, LeClair NP, Conrad MD, Tumwebaze P, Tukwasibwe S, et al. Validation of the ligase detection reaction fluorescent microsphere assay for the detection of Plasmodium falciparum resistance mediating polymorphisms in Uganda. Malar J. 2014;13:95.","journal-title":"Malar J."},{"key":"2645_CR33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4269\/ajtmh.13-0647","volume":"91","author":"GW Mbogo","year":"2014","unstructured":"Mbogo GW, Nankoberanyi S, Tukwasibwe S, Baliraine FN, Nsobya SL, Conrad MD, et al. Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda. Am J Trop Med Hyg. 2014;91:54\u201361.","journal-title":"Am J Trop Med Hyg"},{"key":"2645_CR34","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.1128\/AAC.00920-16","volume":"60","author":"JI Nankabirwa","year":"2016","unstructured":"Nankabirwa JI, Conrad MD, Legac J, Tukwasibwe S, Tumwebaze P, Wandera B, et al. Intermittent preventive treatment with dihydroartemisinin-piperaquine in Ugandan schoolchildrens selects for Plasmodium falciparum transporter polymorphisms that modify drug sensitivity. Antimicrob Agents Chemother. 2016;60:5649\u201354.","journal-title":"Antimicrob Agents Chemother"},{"key":"2645_CR35","first-page":"631","volume":"215","author":"P Tumwebaze","year":"2017","unstructured":"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, et al. Changing antimalarial drug resistance patterns identified by surveillance at three sites in Uganda. J Infect Dis. 2017;215:631\u20135.","journal-title":"J Infect Dis"},{"key":"2645_CR36","unstructured":"WHO. Malaria country profiles. Geneva: World Health Organization; \n                    http:\/\/www.who.int\/malaria\/publications\/country-profiles\/en\/\n                    \n                  . Accessed 23 Feb 2018."},{"key":"2645_CR37","doi-asserted-by":"publisher","first-page":"e000999","DOI":"10.1136\/bmjgh-2018-000999","volume":"3","author":"LC Okell","year":"2018","unstructured":"Okell LC, Reiter LM, Ebbe LS, Baraka V, Bisanzio D, Watson OJ, et al. Emerging implications of policies on malaria treatment: genetic changes in the Pfmdr-1 gene affecting susceptibility to artemether\u2013lumefantrine and artesunate\u2013amodiaquine in Africa. BMJ Glob Health. 2018;3:e000999.","journal-title":"BMJ Glob Health."},{"key":"2645_CR38","unstructured":"WWARN. Artemisinin Molecular Surveyor 2015. \n                    http:\/\/www.wwarn.org\/molecular-surveyor-k13\n                    \n                  . Accessed 21 Dec 2018."},{"key":"2645_CR39","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ijpddr.2017.03.003","volume":"7","author":"RJ Commons","year":"2017","unstructured":"Commons RJ, Thriemer K, Humphreys G, Suay I, Sibley CH, Gu\u00e9rin PJ, et al The Vivax Surveyor: online mapping database for Plasmodium vivax clinical trials. Int J Parasitol Drugs Drug Resist. 2017;7:181\u201390.","journal-title":"Int J Parasitol Drugs Drug Resist"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-019-2645-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12936-019-2645-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-019-2645-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T00:18:07Z","timestamp":1579306687000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-019-2645-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,18]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2645"],"URL":"https:\/\/doi.org\/10.1186\/s12936-019-2645-x","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,18]]},"assertion":[{"value":"20 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"12"}}